Farnesyl-KTTKS Lipopeptide Boosts Fibroblast Collagen Production >200% and Forms Stable Micelles for Enhanced Delivery
Background
Skin aging is characterized by decreased collagen synthesis, leading to wrinkles and loss of elasticity. Topical peptides like KTTKS (Matrixyl™) are used to stimulate collagen production, but their stability and penetration can be limited. There's a need for improved delivery systems and enhanced bioactivity. Lipopeptides, which combine a peptide sequence with a lipid chain, offer a promising strategy to improve peptide bioavailability and self-assembly properties, potentially leading to more effective cosmetic and therapeutic applications. This study explores a novel lipopeptide design to address these challenges, aiming for superior collagen stimulation and broader utility, including anti-inflammatory benefits, which are crucial for skin repair and wound healing.
Study Design
Researchers synthesized farnesyl-mercapto(diethylene glycol)-KTTKS (FMdEG-KTTKS), a lipopeptide conjugate with the KTTKS collagen-stimulating sequence. Its collagen-stimulating activity was assessed in vitro using fibroblast cell cultures, comparing efficacy against conventional stimulants. Self-assembly was characterized via fluorescence probe measurements for CMC, cryo-TEM, and SAXS for micelle structure. Anti-inflammatory activity was evaluated by measuring nitrite production in macrophage cells challenged with bacterial lipopolysaccharide (LPS). A fibroblast monolayer scratch assay modeled skin injury and assessed repopulation.